NT-proBNP levels did not differ significantly by prior CRT, which is in agreement with an improved ability of novel echocardiographic methods to better detect late subclinical LV dysfunction in asymptomatic childhood cancer survivors than natriuretic peptides assays [32,33,34]. This evidence concerns the gene NPPB and childhood malignant neoplasm.